Welcome to Ravenbhel Healthcare Pvt. Ltd.
We are pleased to introduce Ravenbhel, a rapidly growing Indian pharma company committed to developing, manufacturing and marketing diverse portfolio of products. Our core strength lies in contract development, up scaling and manufacturing differentiated formulations. Various national and multi-national pharmaceutical companies across geographies rely on our expertise to deliver world class quality products.
Ravenbhel complies with various National / International regulatory norms and standards. We strive hard to make a difference in people lives, through our innovative healthcare solutions. We have two state of the art WHO GMP manufacturing units that produce various general category formulations that comprises of tablets, oral liquids, capsules and sachets. New state of the art manufacturing facility under the name of Ravenbhel Biotech a sister concern of Ravenbhel Healthcare Pvt. Ltd., which has become operational in May is USDFA/PIC’s/UKMHRA compliant.
Our clients list includes quality conscious market leaders like Novartis, Abbott, Zydus Cadila, Torrent Pharma, Intas, Troikaa, Eris, Emcure, Panacea Biotech, IPCA, Ajanta Pharma, Mankind, Glenmark, Aristo & Medley and many more. Ravenbhel has a strong R&D that can meet the evolving demands of the future. We have an in-house facility for conducting trials, pilot and upscale batches. The company holds the credit of doing 21 Bio Equivalence studies, successfully.
We at Ravenbhel continuously invest in our people, to develop and retain a team of committed professionals, which ensure optimal quality processes at each stage of manufacturing.
Our motto is that client comes first, we in-turn foster long term strategic and progressive relationships with our partners. We produce the quality you need, the availability you desire and the affordability the market dictates.